Preliminary results positive for Moderna mRNA flu vaccine

Nasal vaccine may aid fight against new viral variants
10 December 2021
Switzerland gives green light for children’s Covid jabs
11 December 2021

Preliminary results positive for Moderna mRNA flu vaccine

US biotech company Moderna on Friday announced promising data from an early-stage human trial of its mRNA flu shot, based on the same technology used in its successful COVID-19 vaccine.

Comments are closed.